Researches announce successful intra-neuronal antibody delivery without a viral vector
Global virus deaths hit record high as EU approves second vaccine
6 January 2021Britain ahead of entire EU on vaccines
6 January 2021Researches announce successful intra-neuronal antibody delivery without a viral vector
CytoDel, Inc., a privately-held corporation, today announces the publication of preclinical data on the company’s lead product, Cyto-111, in the peer-reviewed journal, Science Translational Medicine.
